Market Executive Summary
Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
Global Gene Editing market is projected to reach US$ 5441.3 million in 2029, increasing from US$ 3093.1 million in 2022, with the CAGR of 7.9% during the period of 2023 to 2029.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Editing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Merck
Horizo??n Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
Segment by Type
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Segment by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gene Editing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Zinc finger nucleases (ZFNs)
1.2.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.4 CRISPR-Cas system
1.3 Market by Application
1.3.1 Global Gene Editing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotechnology & Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Market Perspective (2018-2029)
2.2 Gene Editing Growth Trends by Region
2.2.1 Global Gene Editing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Editing Historic Market Size by Region (2018-2023)
2.2.3 Gene Editing Forecasted Market Size by Region (2024-2029)
2.3 Gene Editing Market Dynamics
2.3.1 Gene Editing Industry Trends
2.3.2 Gene Editing Market Drivers
2.3.3 Gene Editing Market Challenges
2.3.4 Gene Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Players by Revenue
3.1.1 Global Top Gene Editing Players by Revenue (2018-2023)
3.1.2 Global Gene Editing Revenue Market Share by Players (2018-2023)
3.2 Global Gene Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Editing Revenue
3.4 Global Gene Editing Market Concentration Ratio
3.4.1 Global Gene Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Revenue in 2022
3.5 Gene Editing Key Players Head office and Area Served
3.6 Key Players Gene Editing Product Solution and Service
3.7 Date of Enter into Gene Editing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Editing Breakdown Data by Type
4.1 Global Gene Editing Historic Market Size by Type (2018-2023)
4.2 Global Gene Editing Forecasted Market Size by Type (2024-2029)
5 Gene Editing Breakdown Data by Application
5.1 Global Gene Editing Historic Market Size by Application (2018-2023)
5.2 Global Gene Editing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Editing Market Size (2018-2029)
6.2 North America Gene Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Editing Market Size by Country (2018-2023)
6.4 North America Gene Editing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Market Size (2018-2029)
7.2 Europe Gene Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Editing Market Size by Country (2018-2023)
7.4 Europe Gene Editing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Market Size (2018-2029)
8.2 Asia-Pacific Gene Editing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Editing Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Editing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Editing Market Size (2018-2029)
9.2 Latin America Gene Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Editing Market Size by Country (2018-2023)
9.4 Latin America Gene Editing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Market Size (2018-2029)
10.2 Middle East & Africa Gene Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Editing Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Editing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Editing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Gene Editing Introduction
11.2.4 Merck Revenue in Gene Editing Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Horizo??n Discovery
11.3.1 Horizo??n Discovery Company Detail
11.3.2 Horizo??n Discovery Business Overview
11.3.3 Horizo??n Discovery Gene Editing Introduction
11.3.4 Horizo??n Discovery Revenue in Gene Editing Business (2018-2023)
11.3.5 Horizo??n Discovery Recent Development
11.4 Sangamo BioSciences
11.4.1 Sangamo BioSciences Company Detail
11.4.2 Sangamo BioSciences Business Overview
11.4.3 Sangamo BioSciences Gene Editing Introduction
11.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2018-2023)
11.4.5 Sangamo BioSciences Recent Development
11.5 Integrated DNA Technologies
11.5.1 Integrated DNA Technologies Company Detail
11.5.2 Integrated DNA Technologies Business Overview
11.5.3 Integrated DNA Technologies Gene Editing Introduction
11.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2018-2023)
11.5.5 Integrated DNA Technologies Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Gene Editing Introduction
11.6.4 Lonza Revenue in Gene Editing Business (2018-2023)
11.6.5 Lonza Recent Development
11.7 New England Biolabs
11.7.1 New England Biolabs Company Detail
11.7.2 New England Biolabs Business Overview
11.7.3 New England Biolabs Gene Editing Introduction
11.7.4 New England Biolabs Revenue in Gene Editing Business (2018-2023)
11.7.5 New England Biolabs Recent Development
11.8 OriGene Technologies
11.8.1 OriGene Technologies Company Detail
11.8.2 OriGene Technologies Business Overview
11.8.3 OriGene Technologies Gene Editing Introduction
11.8.4 OriGene Technologies Revenue in Gene Editing Business (2018-2023)
11.8.5 OriGene Technologies Recent Development
11.9 Transposagen Biopharmaceuticals
11.9.1 Transposagen Biopharmaceuticals Company Detail
11.9.2 Transposagen Biopharmaceuticals Business Overview
11.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
11.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2018-2023)
11.9.5 Transposagen Biopharmaceuticals Recent Development
11.10 Editas Medicine
11.10.1 Editas Medicine Company Detail
11.10.2 Editas Medicine Business Overview
11.10.3 Editas Medicine Gene Editing Introduction
11.10.4 Editas Medicine Revenue in Gene Editing Business (2018-2023)
11.10.5 Editas Medicine Recent Development
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Detail
11.11.2 CRISPR Therapeutics Business Overview
11.11.3 CRISPR Therapeutics Gene Editing Introduction
11.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2018-2023)
11.11.5 CRISPR Therapeutics Recent Development
11.12 RGen Solutions
11.12.1 RGen Solutions Company Detail
11.12.2 RGen Solutions Business Overview
11.12.3 RGen Solutions Gene Editing Introduction
11.12.4 RGen Solutions Revenue in Gene Editing Business (2018-2023)
11.12.5 RGen Solutions Recent Development
11.13 Sigma-Aldrich
11.13.1 Sigma-Aldrich Company Detail
11.13.2 Sigma-Aldrich Business Overview
11.13.3 Sigma-Aldrich Gene Editing Introduction
11.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2018-2023)
11.13.5 Sigma-Aldrich Recent Development
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Detail
11.14.2 GeneCopoeia Business Overview
11.14.3 GeneCopoeia Gene Editing Introduction
11.14.4 GeneCopoeia Revenue in Gene Editing Business (2018-2023)
11.14.5 GeneCopoeia Recent Development
11.15 Genscript Biotech
11.15.1 Genscript Biotech Company Detail
11.15.2 Genscript Biotech Business Overview
11.15.3 Genscript Biotech Gene Editing Introduction
11.15.4 Genscript Biotech Revenue in Gene Editing Business (2018-2023)
11.15.5 Genscript Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
List of Figures
List of Tables
Table 1. Global Gene Editing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Zinc finger nucleases (ZFNs)
Table 3. Key Players of Transcription Activator-Like Effector-based Nucleases (TALENs)
Table 4. Key Players of CRISPR-Cas system
Table 5. Global Gene Editing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Editing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Gene Editing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gene Editing Market Share by Region (2018-2023)
Table 9. Global Gene Editing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Gene Editing Market Share by Region (2024-2029)
Table 11. Gene Editing Market Trends
Table 12. Gene Editing Market Drivers
Table 13. Gene Editing Market Challenges
Table 14. Gene Editing Market Restraints
Table 15. Global Gene Editing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gene Editing Market Share by Players (2018-2023)
Table 17. Global Top Gene Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2022)
Table 18. Ranking of Global Top Gene Editing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Gene Editing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Editing Product Solution and Service
Table 22. Date of Enter into Gene Editing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Editing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gene Editing Revenue Market Share by Type (2018-2023)
Table 26. Global Gene Editing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Gene Editing Revenue Market Share by Type (2024-2029)
Table 28. Global Gene Editing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gene Editing Revenue Market Share by Application (2018-2023)
Table 30. Global Gene Editing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Gene Editing Revenue Market Share by Application (2024-2029)
Table 32. North America Gene Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Gene Editing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Gene Editing Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Gene Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Gene Editing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Gene Editing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Gene Editing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Gene Editing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Gene Editing Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Gene Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Gene Editing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Gene Editing Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Gene Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Gene Editing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Gene Editing Market Size by Country (2024-2029) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Gene Editing Product
Table 50. Thermo Fisher Scientific Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Gene Editing Product
Table 55. Merck Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Horizo??n Discovery Company Detail
Table 58. Horizo??n Discovery Business Overview
Table 59. Horizo??n Discovery Gene Editing Product
Table 60. Horizo??n Discovery Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 61. Horizo??n Discovery Recent Development
Table 62. Sangamo BioSciences Company Detail
Table 63. Sangamo BioSciences Business Overview
Table 64. Sangamo BioSciences Gene Editing Product
Table 65. Sangamo BioSciences Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 66. Sangamo BioSciences Recent Development
Table 67. Integrated DNA Technologies Company Detail
Table 68. Integrated DNA Technologies Business Overview
Table 69. Integrated DNA Technologies Gene Editing Product
Table 70. Integrated DNA Technologies Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 71. Integrated DNA Technologies Recent Development
Table 72. Lonza Company Detail
Table 73. Lonza Business Overview
Table 74. Lonza Gene Editing Product
Table 75. Lonza Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 76. Lonza Recent Development
Table 77. New England Biolabs Company Detail
Table 78. New England Biolabs Business Overview
Table 79. New England Biolabs Gene Editing Product
Table 80. New England Biolabs Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 81. New England Biolabs Recent Development
Table 82. OriGene Technologies Company Detail
Table 83. OriGene Technologies Business Overview
Table 84. OriGene Technologies Gene Editing Product
Table 85. OriGene Technologies Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 86. OriGene Technologies Recent Development
Table 87. Transposagen Biopharmaceuticals Company Detail
Table 88. Transposagen Biopharmaceuticals Business Overview
Table 89. Transposagen Biopharmaceuticals Gene Editing Product
Table 90. Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 91. Transposagen Biopharmaceuticals Recent Development
Table 92. Editas Medicine Company Detail
Table 93. Editas Medicine Business Overview
Table 94. Editas Medicine Gene Editing Product
Table 95. Editas Medicine Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 96. Editas Medicine Recent Development
Table 97. CRISPR Therapeutics Company Detail
Table 98. CRISPR Therapeutics Business Overview
Table 99. CRISPR Therapeutics Gene Editing Product
Table 100. CRISPR Therapeutics Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 101. CRISPR Therapeutics Recent Development
Table 102. RGen Solutions Company Detail
Table 103. RGen Solutions Business Overview
Table 104. RGen Solutions Gene Editing Product
Table 105. RGen Solutions Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 106. RGen Solutions Recent Development
Table 107. Sigma-Aldrich Company Detail
Table 108. Sigma-Aldrich Business Overview
Table 109. Sigma-Aldrich Gene Editing Product
Table 110. Sigma-Aldrich Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 111. Sigma-Aldrich Recent Development
Table 112. GeneCopoeia Company Detail
Table 113. GeneCopoeia Business Overview
Table 114. GeneCopoeia Gene Editing Product
Table 115. GeneCopoeia Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 116. GeneCopoeia Recent Development
Table 117. Genscript Biotech Company Detail
Table 118. Genscript Biotech Business Overview
Table 119. Genscript Biotech Gene Editing Product
Table 120. Genscript Biotech Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 121. Genscript Biotech Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Editing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gene Editing Market Share by Type: 2022 VS 2029
Figure 3. Zinc finger nucleases (ZFNs) Features
Figure 4. Transcription Activator-Like Effector-based Nucleases (TALENs) Features
Figure 5. CRISPR-Cas system Features
Figure 6. Global Gene Editing Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Gene Editing Market Share by Application: 2022 VS 2029
Figure 8. Biotechnology & Pharmaceutical Companies Case Studies
Figure 9. Academic & Government Research Institutes Case Studies
Figure 10. Contract Research Organizations Case Studies
Figure 11. Gene Editing Report Years Considered
Figure 12. Global Gene Editing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Gene Editing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gene Editing Market Share by Region: 2022 VS 2029
Figure 15. Global Gene Editing Market Share by Players in 2022
Figure 16. Global Top Gene Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gene Editing Revenue in 2022
Figure 18. North America Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Gene Editing Market Share by Country (2018-2029)
Figure 20. United States Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gene Editing Market Share by Country (2018-2029)
Figure 24. Germany Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Gene Editing Market Share by Region (2018-2029)
Figure 32. China Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Gene Editing Market Share by Country (2018-2029)
Figure 40. Mexico Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Gene Editing Market Share by Country (2018-2029)
Figure 44. Turkey Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Gene Editing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 48. Horizo??n Discovery Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 49. Sangamo BioSciences Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 50. Integrated DNA Technologies Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 51. Lonza Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 52. New England Biolabs Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 53. OriGene Technologies Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 54. Transposagen Biopharmaceuticals Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 55. Editas Medicine Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 56. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 57. RGen Solutions Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 58. Sigma-Aldrich Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 59. GeneCopoeia Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 60. Genscript Biotech Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
